- Report
- February 2025
- 180 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- March 2025
- 185 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 185 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- November 2024
- 110 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- October 2024
- 189 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 196 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- March 2025
- 89 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- January 2025
- 123 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- August 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- March 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- April 2024
- 120 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- July 2024
- 185 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- December 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- May 2023
- 212 Pages
Global
From €1861EUR$1,950USD£1,559GBP
€3722EUR$3,900USD£3,119GBP
- Report
- December 2022
- 93 Pages
Global
From €5249EUR$5,500USD£4,398GBP
- Report
- April 2019
- 153 Pages
Global
From €1312EUR$1,375USD£1,099GBP
€2625EUR$2,750USD£2,199GBP

The Kidney Transplant market is a subset of the biotechnology industry that focuses on the development of treatments and technologies related to kidney transplantation. This includes the development of new drugs, medical devices, and surgical techniques to improve the safety and efficacy of kidney transplantation. Additionally, the market includes research into the development of new immunosuppressive drugs to reduce the risk of organ rejection.
The Kidney Transplant market is highly competitive, with many companies vying for a share of the market. Companies in the market include Astellas Pharma, Novartis, Roche, Merck, and Pfizer. Additionally, there are a number of smaller companies that specialize in the development of new treatments and technologies related to kidney transplantation. Show Less Read more